COMMUNIQUÉS West-GlobeNewswire

ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Decision
06/05/2019
EDISON, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
GBT Announces New Employment Inducement Grants
06/05/2019
SOUTH SAN FRANCISCO, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on May 1, 2019, the compensation committee of GBT’s board of directors granted nine [...]
Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate Update
06/05/2019
EMA grants PRIME eligibility for KB103 (bercolagene telserpavec) to treat dystrophic epidermolysis bullosa Krystal Biotech announces five presentations of clinical and preclinical data at the Society for Investigative [...]
RavenQuest Awarded its First Cannabis Sales License from Health Canada
06/05/2019
VANCOUVER, British Columbia, May 06, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally-licensed producer of cannabis, is pleased to [...]
iCAD Appoints R. Scott Areglado as Chief Financial Officer
06/05/2019
NASHUA, N.H., May 06, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today appointed R. Scott Areglado as Chief [...]
Athenex Announces $100 Million Private Placement
06/05/2019
BUFFALO, N.Y., May 06, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
BioSig Technologies Completes Patient Cases at Indiana University
06/05/2019
Third Center to Use PURE EP(tm) System Santa Monica, CA, May 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform [...]
Engage Therapeutics Presents Data from Part 1, Open-label Run-in of StATES Phase 2b Study of Staccato® Alprazolam at 2019 American Academy of Neurology Annual Meeting
06/05/2019
– Eight (8) patients with predictable generalized or focal epileptic seizures treated with Staccato alprazolam – – 62.5 percent of patients respond with cessation of seizure activity within two minutes of therapy [...]
Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates
06/05/2019
WALTHAM, Mass., May 06, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark
06/05/2019
NEWTOWN, Pa., May 06, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
Adaptimmune Reports First Quarter 2019 Financial Results
06/05/2019
- Clinical update issued in a separate announcement - - Financial guidance updated: funded into Q3 2020 - PHILADELPHIA and OXFORD, United Kingdom, May 06, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: [...]
Biogen Presents Data at 2019 AAN Annual Meeting Affirming Longer-Term Safety and Durability of Treatment with SPINRAZA® (nusinersen)
06/05/2019
Treatment with SPINRAZA resulted in clinically meaningful improvements in motor-function and survival in individuals with spinal muscular atrophy Treating pre-symptomatic infants with SPINRAZA helped patients in the [...]
VitalHub Announces Appointment of Francis Shen to Board of Directors
06/05/2019
TORONTO, May 06, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce that Francis Shen, founder, former Chairman and co-CEO of Aastra Technologies Limited (“Aastra”) has been [...]
Aptinyx to Report First Quarter 2019 Financial Results on Tuesday, May 14, 2019
06/05/2019
EVANSTON, Ill., May 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today [...]
Co-Founder of Nasdaq Global Corporate Solutions Group Joins Board of THC Therapeutics-THCT
06/05/2019
Enzo Villani brings over 20 years of experience in developing businesses through “buy and build” strategies leveraging strategic partnerships, M&A, and business development. LAS VEGAS, May 06, 2019 (GLOBE NEWSWIRE [...]
Unum Therapeutics to Host First Quarter 2019 Financial Results Conference Call and Webcast on May 13, 2019 at 8:00 A.M. ET
06/05/2019
CAMBRIDGE, Mass., May 06, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer using its novel [...]
Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™ for the Treatment of Behavioral Symptoms Associated with Fragile X Syndrome (FXS)
06/05/2019
- Designation Facilitates and Expedites Development of Drugs for Patients with Serious Unmet Medical Needs - - Enrollment Progressing in Pivotal CONNECT-FX Trial of Zygel in FXS, with Data Expected in the Second Half of [...]
Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors
06/05/2019
- Partial responses in 4 out of 5 synovial sarcoma patients treated with ~10 billion cells, with tumor shrinkage in nearly all assessed synovial sarcoma patients in the ADP-A2M4 pilot study - - Initiating SPEARHEAD-1 [...]
Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019
06/05/2019
Conference Call and Webcast Scheduled for Friday, May 10, 2019 at 8:00 a.m. ET MALVERN, Pa., May 06, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH) today announced that it will report first quarter financial [...]

Pages